C
에스디생명공학
217480KOSDAQ54.8 / 100
Reference Date: 2026-09-08
Financial Score16.0 / 40
News Sentiment18.8 / 25
Momentum10.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Roughly flat over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
Esd Life Science operates in two main business segments: cosmetics and food. In the cosmetics division, it sells a variety of products such as SNP brand masks and patches both domestically and internationally. The food division launched the 'Ogam Shikdak' brand in 2022, focusing on convenient food products like solid stock broth.
Number of Employees
63people
Average Salary
56.8M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 15.004.0Point
PBR
1.83Industry Average 1.201.0Point
1.5x industry avg (risky)
ROE
-25.09Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
2.27Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2023~20253.0 / 10 points
Revenue Growth Rate
0.0 / 3
Avg ▼19.7% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲31.9% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -29.5% (declining, 3yr)
Detailed News Sentiment
1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 75
- Positive에스디생명공학, 5대 1 주식병합 결정
에스디생명공학의 주식병합 결정으로 인해 주식수 감소와 액면가 상승이 예상되어 투자자들에게 긍정적 신호를 제공.
Detailed Momentum
52-week position4.0Point
52w mid range (50%)
Current 499Won52-week high 49952-week low 499
1-month return3.0Point
1m 0% (flat)
Volume trend3.0Point
Volume flat
Detailed Disclosure
5 totalPositive 0Neutral 5Negative 0
- Neutral기타시장안내 (개선계획 이행내역서 제출)2026-09-03
- Neutral주주총회소집결의 (임시주주총회)2026-08-27
- Neutral주식병합결정2026-08-27
- Neutral주주명부폐쇄기간또는기준일설정2026-08-27
- Neutral기타시장안내 (개선기간 종료에 따른 상장폐지 여부 결정 안내)2026-08-12